Stocks in Action: Sartorius Stedim Biotech, Süss Microtec, JENOPTIK, Vonovia, and RTL Group.
Reading Time: 3 minutes
Stock 1.) Sartorius Stedim Biotech benefits from increasing R&D investments in the pharma and biotech sector, Goldman Sachs raises to Buy with a price target of 214 Euros! A noteworthy Buy rating comes on Monday from Goldman Sachs analysts for Sartorius Stedim Biotech. The subsidiary of the life sciences specialist Sartorius is a key player in biopharmaceuticals, providing manufacturers of biopharmaceuticals with solutions in cell cultivation, fermentation, filtration, purification, and fluid management. This positions the company to benefit from...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
